fbpx
FYiDoctors & CRO Online

FYidoctors Provides Support to Members for Online COPE-accredited CE

FYi doctors and CRO JOURNAL are pleased to announce a new program that supports optometrist members of the FYidoctors network to achieve Category A COPE-accredited CE hours at a member discount through the CRO (Clinical & Refractive Optometry) online CE platform (www.crojournal.com).

The FYidoctors member discount program is available immediately and will be in effect until August 31, 2020. 

FYidoctors are the first optometry group to take advantage of CRO’s member network affiliation program. Through a simple member sign-on process, FYIdoctors will be automatically enrolled in the program to achieve the discounts.  

FYidoctors Chair and CEO, AL Ulsifer, said, “I cannot help but feel tremendous pride that in times where doctors are now wondering how they will pay the bills, that many want to use this time to improve their skills as optometrists.  We are pleased to work with CRO Journal to provide a timely support system for our doctors to continue to improve their skill set and meet their regulated CE requirements.”

“We are honoured to be working with the FYi doctor group as the first optometry network to leverage  CRO member program benefits. Our online CE technology platform makes it easy to scale up and integrate member networks. We are pleased to make this contribution to the profession during these trying times.” said David Pietrobon, Publisher of CRO (Clinical & Refractive Optometry) Journal.

 What Does CRO JOURNAL Offer?
CROJOURNAL.com offers category A COPE-accredited CE courses starting at $17.50 per 1-hour course. There are also a several complimentary courses available.  A member account is free and no credit card is required to register. Members may purchase pre-paid packages of 5 or 10 CE credit hours at value prices or purchase a premium subscription.

CLICK HERE TO VIEW CRO Online.

CRO Group Membership inquires may be addressed to:
David Pietrobon, B.Sc. (Hons), MBA, CRO Publisher

EMAIL:    dpietrobon@vuepoint.ca
PHONE:  1 (226)  780 6871 

Featured Posts

Bausch + Lomb

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More
Onesight Essilorluxottica logo et SPECS 30

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read more
Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read more
Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read more
Bausch + Lomb

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read more
Bausch + Lomb

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More
Onesight Essilorluxottica logo et SPECS 30

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read More
Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read More
Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read More
Bausch + Lomb

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read More
Bausch + Lomb

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More
Onesight Essilorluxottica logo et SPECS 30

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read more
Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read more
Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read more
Bausch + Lomb

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read more
Bausch + Lomb

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More
Onesight Essilorluxottica logo et SPECS 30

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read more
Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read more
Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read more
Bausch + Lomb

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read more